Talphera Inc.

TLPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.17

$0 (0.00%)

At close: Sep 22, 2026, 4:00 PM ET

$1.11

-$0.06 (-5.13%)

After-hours: Sep 22, 2026, 7:53 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $60.72M

1D Range

1.15 1.18

52W Range

0.69 1.57

Valuation (TTM)

PE -3.66

PB 4.22

EV/EBITDA -2.94

Valuation (NTM)

Forward PE N/A

Forward PEG -0.73

Price Target $3

Cash Flow

FCF Yield -20.2%

SBC Adj. FCF Yield -21.5%

SBC Impact -6.5%

Margins

Gross Margin 100.0%

Operating Margin -1474700.0%

FCF Margin -1227000.0%

Growth (CAGR)

Revenue 3Y | 5Y -87.4% | -79.9%

Dil EPS 3Y | 5Y 35.3% | -247.3%

FCF 3Y | 5Y 8.0% | 25.3%

Returns

ROA -56.2%

ROE -87.3%

ROIC -65.2%

Financial Health

Net Cash

$17.08M

Current Ratio 4.29

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimenta...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 12

IPO Date Feb 10, 2011

Website talphera.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.